We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
PREGABALIN-AFT (AFT Pharmaceuticals Pty Ltd)
Product name
PREGABALIN-AFT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
157 working days (255)
Active ingredients
pregabalin
Registration type
New generic medicine
Indication
PREGABALIN-AFT (oral solution) is indicated for the treatment of neuropathic pain in adults.
PREGABALIN-AFT is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.